+ All Categories
Home > Documents > The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious...

The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious...

Date post: 01-Apr-2015
Category:
Upload: nyla-weller
View: 228 times
Download: 8 times
Share this document with a friend
43
The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC
Transcript
Page 1: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

The Use and Misuse of Antimicrobials in NICU

Ban AL-Sayyed, MD, FAAP, FIDSAPediatric Infectious Diseases Consultant

KFSH& RC

Page 2: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

A 20 day old male, X- 27 wk, 900 gm. Developed fever of 38.7 C0 and apnea. He’s been intubated since admission. An axillary central line was inserted 10 days ago. He received several PRBC transfusions and two courses of IV antibiotics. Blood cultures were sent and they are pending.

Is he septic?

What is your differential?

What is your empirical antibiotic coverage?

Page 3: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Sepsis in Neonates

• Early onset sepsis (EOS)

Less than 48 to 72 hours

Incidence of EOS in VLBW is 2%

• Late onset sepsis; (LOS)

Incidence is higher in premature infants

15% for 1001-1250 g

20-25% for infants <1500 g

28% for infants 751- 1000 g

43% for infants <750 g

Page 4: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Incidence of Early- and Late-onset Sepsis during 1978-2006

Neonatology 2009; 97: 22-28

GBS Screening

Page 5: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Distribution of Gram-positive and Gram-negative Microorganisms causing Early-Onset

Sepsis during 1978-2006

Neonatology 2009; 97: 22-28

Page 6: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Early Onset Sepsis Annual Cumulative Incidence (NICU 1997 and 2007)

Antibiotics

GBS

Page 7: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.
Page 8: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

What is a Nosocomial Infection?

• CDC:

Any infection occurring after admission to hospital , not transplacental

• Risk factors:

- Gestational age and birth weight

- Maternal infection

- Intrinsic Immunologic Factors:

Poor chemotaxis, low levels immunoglobulins, low CH50

Decreased number of CD3, CD4, CD8, and NK cells

- Poor skin integrity

- Immature gastrointestinal development

- Extrinsic Factors: Instrumentation, Procedures

Page 9: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

PEDIATRICS Vol. 103 No. 4 April 1999

Page 10: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Late Onset Sepsis Annual Cumulative Incidence (NICU 1997 and 2007)

Page 11: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Neonatology 2009; 97: 22-28

Page 12: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Coag neg Staph

Neonatology 2009; 97: 22-28

Page 13: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Journal of Perinatology (2004) 24, 382–388

Pathogen Distribution

Page 14: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Pathogen Distribution in Abha

EMHJ • Vol. 16 No. 1 • 2010

Page 15: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Summary

• Pathogen distribution:

Gram positive organisms 50-60%

Gram negative organisms 20%

Fungal pathogens increasing- ~ 10%• Clinical signs and symptoms:

Non specific

Temperature instability (51%), jaundice (35%), respiratory distress (33%), feeding problems (28%), lethargy (25%), pallor and/or cyanosis (24%), apneic attacks and/or bradycardias (22%), and distended abdomen (17%)

Page 16: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Back to the Case The culture from CVC came back

as: Gram negative bacilli. You called the Lab, and the technician said,” it ferments lactose.”

How will you change your coverage?

Would you do a combination therapy? Why?

Page 17: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Antibiotic Use in NICU

Page 18: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Variation in Antibiotic Use in NICU

J Antimicrob Chemother doi:10. 1093/jac/dkq107

Page 19: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

CDC 12-Step Guidelines

• http://www.kliinikum.ee/infektsioonikontrolliteenistus/doc/oppematerjalid/children.pdf

• Multicenter retrospective observational study of antibiotic use targeted 4 tertiary NICUs to assess adherence

• Antibiotic regimens, clinical and microbiological data, indications for initiation and continuation of antibiotics (after 72 h of use) were recorded

PID Journal • Volume 28, Number 12, December 2009

Page 20: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.
Page 21: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Definition of Inappropriate Use

PID Journal • Volume 28, Number 12, December 2009

Page 22: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.
Page 23: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Summary

• 200 neonates received 323 antibiotic courses totaling 3344 antibiotic-days

• 28% of courses and 24% of days were judged to be nonadherent to a CDC 12-Step Campaign

• Inappropriate use was more common with continuation of antibiotics (39%) than with initiation (4%) of therapy

• Vancomycin was the most commonly used drug of which 284 (32%) days were considered inappropriate

• Carbapenems were used less frequently (n = 310 antibiotic-days), and 132 (43%) of these days were inappropriate

Page 24: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Summary 2• Nonadherence to CDC 12 step was because of :

- Failure to narrow the spectrum

- Prolonged antibiotic prophylaxis after surgeries and certain procedures

- Treatment of colonization rather than real infection

- No targeting of the pathogen

Page 25: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Back to Case

The patient’s antibiotics were changed from ceftazidime and vancomycin to meropenem + gentamcin + vancomycin pending sensitivity of the CVC blood culture isolate. The identification revealed Klebsiella oxytoca. The tracheal aspirate grew Stenotrophomonas maltophilia and the patient had a positive nasal PCR for MRSA.

Do you agree?

How can you modify the antibiotics?

Page 26: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Emerging Infections

Page 27: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.
Page 28: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Courtesy of CDC

Page 29: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Courtesy of CDC

Page 30: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Courtesy of CDC

Page 31: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

J Antimicro Chemother. 2000 Jul; 58 (1): 205-10

Page 32: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Facts about ESBL Gram-negative species

• These organisms are resistant to all ß-Lactam antibiotics except cephamycins (cefoxitin, cefotetan) and carbapenems

• They are frequently resistant to many other classes of antibiotics, including aminoglycosides and fluoroquinolones

• High rates of third-generation cephalosporin use have been implicated as a major cause of this problem. (Ceftazidime)

• Carbapenems are the most active and reliable treatment options for infections caused by ESBL isolates

• Overuse of carbapenems may lead to resistance of other gram-negative organisms; Pseudomonas

Page 33: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Antibiotic Stewardship

Page 34: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

IDSA Guidelines

• Prospective audit with intervention and feedback• Education• Guidelines and clinical pathways• Antimicrobial cycling• Antimicrobial order forms• Combination therapy• Streamlining or de-escalation of therapy• Dose optimizationThe application in pediatrics is not commonly used

Page 35: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Antibiotic RestrictionSeoul National Children’s University

• Hospital High rates of ESBL K pneumoniae (64%) in late 1990’s

• 2002-2003 campaign to decrease use of extended-spectrum cephalosporins

• Encouraged use of piperacillin/tazobactam

• Reductions in overall rates, did not elaborate on other interventions

Page 36: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.
Page 37: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Restriction of Cephalosporins and ESBL in a NICU

indianpediatrics.net/sep2010/785.pdf

Page 38: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Antibiotic Cycling

A recent systematic review found only four studies worthy of inclusion and concluded that antibiotic cycling could not, at present, be promoted as a methodology to control

resistance

Page 39: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Journal of Neonatology Vol. 21, No. 1, Jan. - Mar. 2007

Page 40: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Antibiotic cycling: more than it might seem?

• Good for Gram-negative resistance control

• Where antibiotic cycling is introduced and no specific susceptibility problem exists, it can still reduce background levels of resistance for Gram-negative pathogens, not for Gram-positive organisms

• Helps in reduction of ICU ventilator-associated pneumonia, less convincingly for other types of sepsis.

Page 41: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

continue

• Where antibiotic cycling is introduced, there is an improvement in effective antibiotic prescribing in ICU

• There is a reduction in ICU mortality rates

Journal of Antimicrobial Chemotherapy (2005) 55, 1–5

Page 42: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

Journal of Neonatology Vol. 21, No. 1, Jan. - Mar. 2007

Page 43: The Use and Misuse of Antimicrobials in NICU Ban AL-Sayyed, MD, FAAP, FIDSA Pediatric Infectious Diseases Consultant KFSH& RC.

“The ideal way to get rid of any infectious disease would be to shoot instantly every person who comes down with it."

H. L. Mencken


Recommended